MoneyWorks4Me

Sun Pharma Advanced Research Company informs about disclosure

03 Jun 2021 Evaluate
In compliance with Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) (Amendments) Regulations, 2018, Sun Pharma Advanced Research Company has informed that it submitted the Related Party Transactions on consolidated basis, in accordance with the applicable accounting standards, for the half year ended 31st March 2021.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sagility 45.94
Prime Focus 352.35
Knowledge RealtyTrt. 113.71
Indegene 596.10
Syngene Internatl. 385.35
View more..